Syncom Formulations (India) Ltd.

BSE: SYNCOMF524470ISIN INE312C01025

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹20.56+1.47 (+7.70%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹27.53
52W low: ₹10.21
Off 52W high: -25.32%
1M return: -11.07%
3M return: +54.01%
6M return: +43.08%
1Y return: +25.90%
20D avg volume: 9,15,464
50 DMA: ₹20.82
200 DMA: ₹15.35

Key ratios Consolidated

Market cap: ₹1,933 Cr
Current price: ₹20.56
52W high / low: ₹27.53 / ₹10.21
Face value: ₹1.00
P/E: 22.60
P/B: 4.66
EPS (TTM): ₹0.91
Book value / share: ₹4.41
ROE: —
ROCE: 23.80%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-3.68 Cr
Interest cover: 88.17
Dividend yield: 0.49%
Dividend / share (TTM): ₹0.10
Payout: 10.99%
Cash conversion cycle: 73.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	125.53	135.41	115.14	121.72	116.90	148.88	127.53	102.31	87.25	74.57	65.14	63.84
	7.83	14.55	5.50	5.25	6.04	6.94	4.04	4.15	1.34	3.10	4.55	4.00
	133.36	149.97	120.64	126.97	122.94	155.82	131.57	106.46	88.59	77.67	69.69	67.84
	101.10	116.26	95.55	104.93	102.69	132.53	114.31	91.61	78.49	67.64	60.31	59.39
	58.78	67.45	47.45	46.43	59.61	80.16	76.26	68.58	53.03	37.88	37.75	33.25
	18.24	20.55	15.71	15.29	15.68	15.79	7.23	12.66	4.29	5.02	4.50	8.37
	17.17	16.95	17.45	16.73	15.95	14.97	13.95	12.40	9.65	8.69	9.74	9.00
	0.24	0.38	0.26	0.27	0.25	0.12	0.20	0.16	0.39	1.20	1.08	1.08
	1.54	2.48	1.36	1.35	1.34	1.29	1.31	1.30	1.30	1.30	1.45	0.88
	16.29	13.14	15.44	15.83	15.97	15.78	12.20	11.95	12.64	13.76	8.52	9.33
	32.25	33.71	25.09	22.04	20.25	23.29	17.26	14.85	10.10	10.03	9.38	8.45
	0.00	0.00	0.00	0.00	0.04	0.01	0.00	0.00	0.00	0.00	-0.02	0.00
	32.25	33.70	25.09	22.04	20.29	23.30	17.26	14.85	10.10	10.03	9.36	8.45
	7.41	8.53	6.18	5.44	4.54	5.61	4.26	3.74	2.47	2.63	2.36	1.94
	24.85	25.17	18.91	16.60	15.75	17.69	13.00	11.11	7.63	7.41	7.00	6.51
	0.26	0.27	0.23	0.18	0.21	0.16	0.14	0.16	0.11	0.10	0.09	0.08
Key metrics
	34.03	36.56	26.71	23.66	21.88	24.71	18.77	16.31	11.79	12.53	11.89	10.41
	27.10%	27.00%	23.20%	19.40%	18.70%	16.60%	14.70%	15.90%	13.50%	16.80%	18.30%	16.30%
	19.80%	18.60%	16.40%	13.60%	13.50%	11.90%	10.20%	10.90%	8.70%	9.90%	10.70%	10.20%
	—	7.90%	—	5.70%	—	6.60%	—	—	—	—	—	—
	7.40%	-9.00%	-9.70%	19.00%	34.00%	99.70%	95.80%	60.30%	—	—	—	—
	57.80%	42.30%	45.50%	49.40%	106.40%	138.70%	85.70%	70.70%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	497.80	489.17	465.01	263.39	224.25
	33.13	31.34	17.43	13.53	14.60
	530.94	520.51	482.45	276.91	238.85
	417.84	419.43	416.94	242.94	212.29
	220.11	220.94	278.03	131.53	99.46
	69.79	67.23	39.97	27.11	42.61
	68.30	67.09	52.17	35.06	25.87
	1.15	1.16	0.86	4.47	3.13
	6.73	6.53	5.19	4.72	4.54
	60.70	60.38	51.37	41.80	37.06
	113.09	101.08	65.51	33.98	26.56
	0.00	0.04	0.01	-0.02	0.01
	113.08	101.12	65.51	33.95	26.57
	27.56	24.68	16.08	8.64	6.50
	85.53	76.44	49.44	25.31	20.07
	0.94	0.81	0.57	0.34	0.24
Key metrics
	120.96	108.81	71.56	43.14	34.24
	24.30%	22.20%	15.40%	16.40%	15.30%
	17.18%	15.60%	10.60%	9.60%	8.90%
	—	23.80%	18.80%	—	—
	0.44%	5.20%	76.50%	17.50%	—
	48.62%	54.60%	95.30%	26.10%	—
	—	46.41	13.48	—	—
	—	0.76	0.47	—	—
	—	0.00	0.01	—	—
	—	-3.68	3.87	—	—
	—	73.9	83.2	—	—
Balance sheet
	—	533.85	413.28	—	—
	—	330.37	269.97	—	—
	—	5.15	0.71	—	—
	—	110.50	107.55	—	—
	—	62.88	41.33	—	—
	—	33.27	22.19	—	—
	—	89.77	77.53	—	—
	—	74.39	42.80	—	—
	—	103.73	59.31	—	—
	—	1.47	4.58	—	—
	—	1.47	4.58	—	—
	—	0.00	0.00	—	—
	—	414.99	342.16	—	—
Cash flow
	—	58.08	23.44	—	—
	—	-50.62	-18.20	—	—
	—	-3.02	-67.90	—	—
	—	11.67	9.96	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	124.66	134.00	114.59	121.44	116.55	148.46	127.03	101.49	86.83	73.27	63.34	62.39
	7.82	14.23	5.48	5.23	6.02	6.90	3.83	4.18	1.31	2.87	4.35	4.00
	132.48	148.23	120.07	126.67	122.57	155.37	130.85	105.68	88.14	76.14	67.69	66.39
	100.57	115.36	95.03	104.31	102.35	132.37	113.95	91.03	78.05	66.93	59.07	58.25
	58.78	67.45	47.45	46.43	59.61	80.16	76.26	68.58	53.03	37.88	37.75	33.25
	17.33	20.15	15.57	15.35	15.62	15.68	7.13	12.60	4.06	4.89	3.98	8.20
	17.17	16.95	17.45	16.73	15.95	14.97	13.95	12.40	9.65	8.69	9.74	9.00
	0.23	0.37	0.25	0.25	0.24	0.09	0.21	0.16	0.39	1.17	1.08	1.08
	1.54	2.48	1.36	1.35	1.34	1.29	1.31	1.30	1.30	1.30	1.45	0.88
	15.89	12.62	15.12	15.11	15.75	15.78	11.86	11.59	12.25	13.20	—	8.93
	31.91	32.87	25.05	22.36	20.22	23.00	16.91	14.65	10.10	9.21	8.62	8.14
	0.00	0.00	0.00	0.00	0.04	0.01	—	0.00	—	—	-0.02	—
	31.91	32.86	25.05	22.36	20.26	23.01	16.91	14.65	10.10	9.21	8.60	8.14
	7.32	8.29	6.18	5.52	4.53	5.51	4.11	3.70	2.47	2.46	2.18	1.94
	24.59	24.57	18.86	16.84	15.73	17.50	12.79	10.95	7.63	6.75	6.42	6.21
	0.26	0.26	0.23	0.18	0.21	0.16	0.14	0.16	0.11	0.09	0.09	0.08
Key metrics
	33.68	35.71	26.66	23.96	21.84	24.39	18.43	16.11	11.79	11.68	11.13	10.10
	27.00%	26.60%	23.30%	19.70%	18.70%	16.40%	14.50%	15.90%	13.60%	15.90%	17.60%	16.20%
	19.70%	18.30%	16.50%	13.90%	13.50%	11.80%	10.10%	10.80%	8.80%	9.20%	10.10%	10.00%
	—	7.80%	—	5.80%	—	6.60%	—	—	—	—	—	—
	7.00%	-9.70%	-9.80%	19.70%	34.20%	102.60%	100.60%	62.70%	—	—	—	—
	56.30%	40.40%	47.50%	53.80%	106.20%	159.30%	99.20%	76.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	494.69	486.57	462.85	258.36	224.64	219.66
	32.76	30.97	17.19	13.10	14.61	11.99
	527.45	517.54	480.04	271.46	239.25	231.66
	415.27	417.05	415.39	239.68	212.70	205.50
	220.11	220.94	278.03	131.53	99.46	97.41
	68.40	66.70	39.48	26.21	42.61	39.81
	68.30	67.09	52.17	35.06	25.87	22.16
	1.10	1.10	0.85	4.45	3.13	1.36
	6.73	6.53	5.19	4.72	4.54	3.95
	58.74	58.59	50.29	39.89	37.04	37.50
	112.19	100.49	64.65	31.78	26.55	26.15
	0.00	0.04	0.01	-0.02	0.01	0.02
	112.18	100.53	64.66	31.76	26.57	26.18
	27.31	24.52	15.79	8.14	6.50	6.39
	84.86	76.01	48.87	23.62	20.07	19.79
	0.93	0.81	0.57	0.32	0.24	0.26
Key metrics
	120.01	108.16	70.70	40.93	34.24	31.49
	24.26%	22.20%	15.30%	15.80%	15.20%	14.30%
	17.15%	15.60%	10.60%	9.10%	8.90%	9.00%
	—	23.80%	18.60%	—	—	—
	0.24%	5.10%	79.10%	15.00%	2.30%	—
	48.96%	55.50%	106.90%	17.70%	1.40%	—
	—	46.62	13.35	—	—	—
	—	0.77	0.48	—	—	—
	—	0.00	0.01	—	—	—
	—	-4.44	3.35	—	—	—
	—	72.1	83.2	—	—	—
Balance sheet
	—	529.26	409.69	—	—	—
	—	326.03	267.46	—	—	—
	—	5.12	0.69	—	—	—
	—	107.60	106.94	—	—	—
	—	62.85	41.29	—	—	—
	—	33.09	20.39	—	—	—
	—	89.77	77.53	—	—	—
	—	74.29	42.72	—	—	—
	—	101.83	57.97	—	—	—
	—	0.68	4.04	—	—	—
	—	0.68	4.04	—	—	—
	—	0.00	0.00	—	—	—
	—	412.30	339.90	—	—	—
Cash flow
	—	58.29	23.31	—	—	—
	—	-50.64	-18.38	—	—	—
	—	-3.22	-67.59	—	—	—
	—	11.67	9.96	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +29.39%
Sales CAGR 5Y: —
Profit CAGR 3Y: +55.87%
Profit CAGR 5Y: —
Sales YoY (TTM): +0.24%
Profit YoY (TTM): +48.96%

Consolidated

Sales CAGR 3Y: +29.69%
Sales CAGR 5Y: —
Profit CAGR 3Y: +56.17%
Profit CAGR 5Y: —
Sales YoY (TTM): +0.44%
Profit YoY (TTM): +48.62%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 50.58%

Quarter	September 2026	June 2026
Promoter %	50.58%	50.58%

Holder	Type	Holding	Previous	Change
KEDARMAL SHANKARLAL BANKDA	Promoter	12.44%	12.44%	0.00%
VIJAY SHANKARLAL BANKDA	Promoter	10.48%	10.48%	0.00%
PARADISE VYAPAR PRIVATE LIMITED	Promoter Group	5.02%	5.02%	0.00%
ANKIT BANKDA	Promoter Group	4.99%	4.99%	0.00%
ASHA VIJAY BANKDA	Promoter Group	4.90%	4.90%	0.00%
VIMLA BANKDA	Promoter Group	4.26%	4.26%	0.00%
STRAND DEVELOPERS PVT LTD	Promoter Group	3.82%	3.82%	0.00%
VIJAY BANKDA HUF	Promoter Group	1.28%	1.28%	0.00%
PAYAL ANKUR BANKDA	Promoter Group	1.25%	1.25%	0.00%
KEDARMAL SHANKARLAL BANKDA HUF	Promoter Group	1.12%	1.12%	0.00%
SULABH RAHUL BANKDA	Promoter Group	0.99%	0.99%	0.00%
RAHUL BANKDA	Promoter Group	0.02%	0.02%	0.00%
ANKUR VIJAY BANKDA	Promoter Group	0.01%	0.01%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,37,952	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,69,451	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,449	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,26,703	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,19,341	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,13,578	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,243	1,401.75	39.68	14.90%	-0.74% TTM	-47.48% TTM	-6.77%
Mankind Pharma Limited	1,03,881	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	1,02,895	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	90,887	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,147	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	61,956	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Biocon Ltd.	58,897	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Abbott India Ltd. S	56,508	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Gland Pharma Limited	51,934	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	49,458	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
Emcure Pharmaceuticals Limited	42,498	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
GlaxoSmithkline Pharmaceuticals Ltd.	42,363	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,012	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	33,915	1,546.30	90.80	18.10%	—	—	+67.49%
Wockhardt Ltd	32,340	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
PIRAMAL PHARMA LIMITED	31,793	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,838	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
RUBICON RESEARCH LIMITED	28,809	1,716.55	98.59	24.30%	—	—	+164.06%
Syncom Formulations (India) Ltd.	1,962	20.56	22.60	23.80%	+0.44% TTM	+48.62% TTM	+25.90%

Filings & corporate actions

Recent announcements

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to Regulation ....4 Nov 2026 · Board Meeting / Board Meeting
Certificate for Compliance of Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 30th September, 2026.8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Corporate Announcement regarding approval and payment of final dividend.1 Oct 2026 · Corp Action / Dividend Updates
Disclosure under reg 30 of SEBI (LODR) reg 2015 read with sub clause 7 of para A of part A of schedule /// change in directorate.1 Oct 2026 · Company Update / Change in Management
Outcome of 38th AGM1 Oct 2026 · AGM/EGM / AGM
Declaration of Voting result as per regulation 44(3) of SEBI (LODR) regulation 2015.1 Oct 2026 · AGM/EGM / AGM
Declaration of Result of Remote E Voting and E Voting at 38th AGM incompliance with Regulation 44(3) of SEBI (LODR) Regulation, 2015 in relation to 38th AGM of the company held on 30th ....1 Oct 2026 · AGM/EGM / AGM
Submission of proceedings of the 38th Annual General Meeting of the Company held on Wednesday, 30th September, 2026 pursuant to Regulation 30(2) read with Part A of Schedule /// of the ....30 Sep 2026 · AGM/EGM / AGM
Intimation under Regulation 30 of SEBI(LODR) Regulation 2015, Voluntary Waiver/Forgoing of Final Dividend by Promoter/Promoter Group.26 Sep 2026 · Corp Action / Dividend Updates
We would like to inform you that Pursuant to the provisions of SEBI (PIT) Regulation, 2015. The window for dealing in the securities of the company shall remain closed from 1st Oct, 2026 ....24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
We are pleased to inform you that, pursuant to the provision of regulation 42 of SEBI (LODR) regulation, 2015 and section 91 of companies Act, 2013 the "Record Date" has been fixed as Wednesday ....18 Sep 2026 · Corp. Action / Record Date
Submission of copy of newpaper clippings of notice of 38th Annual General Meeting (AGM), Remote E-Voting, Record Date and other details.8 Sep 2026 · Company Update / Newspaper Publication
Pursuant to Reg 36(1)(b) of SEBI (LODR) Regulation, 2015, we hereby inform that company has dispatched the letters to shareholders whose email address is not registered with the company / RTA.7 Sep 2026 · Company Update / General
Submission of Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26 pursuant to regulation 34(2)(f) of SEBI (LODR) Regulations, 20157 Sep 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
We are pleased to submit herewith a copy of the Notice of the 38th AGM of the company, scheduled to be held on Wednesday, 30th day of September, 2026 at 2:00 P.M. through Video Conferencing ....7 Sep 2026 · Company Update / General
Submission of 38th Annual Report along with the Notice of Annual General Meeting to be held on Wednesday, 30th September, 2026 through Video Conferencing ('VC')/ Other Audio Visual Means ....7 Sep 2026 · Others / Reg. 34 (1) Annual Report
Submission of copy of newspaper clippings of notice of 38th Annual General Meeting (AGM), Remote E-Voting, Book Closure and other details.1 Sep 2026 · Company Update / Newspaper Publication
PURSUANT TO REG 30 SEBI, LODR, WE HEREBY SUBMIT THE PRESS RELEASE ISSUED BY THE COMPANY13 Aug 2026 · Company Update / General
Submission of Press Clipping Related to extract of Un-Audited Standalone and Consolidated Financial Result for the Quarter ended on 30th June, 2026.12 Aug 2026 · Company Update / Newspaper Publication
Disclosure under Regulation 30(2) read with Clause 7 of Para A of Schedule /// of the SEBI (LODR) Regulation, 2015: Change in directors, KMP and Senior Management.11 Aug 2026 · Company Update / Change in Management
Corporate Announcement/Information pursuant to Regulation 44 of the SEBI (LODR) Regulation, 2015 regarding providing Remote E-Voting facilities for the 38th Annual General Meeting to be ....11 Aug 2026 · Company Update / General
Appointment of Cost Auditor and Internal Auditor for the FY 2026-27.11 Aug 2026 · Company Update / General
Pursuant to Regulation 33(3) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report thereon ....11 Aug 2026 · Result / Financial Results
We are pleased to inform you that, pursuant to the provision of Regulation 42 of SEBI (LODR) Regulations, 2015 and Section 91 of the Companies Act, 2013 the "Record Date" has been fixed ....11 Aug 2026 · Corp. Action / Dividend
Outcome of the 2/2026-27 Meeting of the Board of Directors of the Company held on Tuesday, 11th August 2026 pursuant to Regulation 30 read with Schedule III(A)(IV) of the SEBI(LODR) Regulations, 2015.11 Aug 2026 · Board Meeting / Outcome of Board Meeting
Revised Intimation for resignation of Mr. Vijay Shankarlal Bankda Managing Director Under Regulation 30 of SEBI (LODR) Regulations, 2015.10 Aug 2026 · Company Update / Resignation of Managing Director
Intimation for Resignation of Mr. Vijay Shankarlal Bankda Managing Director under Regulation 30 of SEBI (LODR) Regulations, 20158 Aug 2026 · Company Update / Resignation of Managing Director
Intimation for Resignation of Mr. Rahul Vijay Bankda Chief Financial Officer (CFO) under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 20158 Aug 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
Intimation for Resignation of Mr. Kedarmal Shankarlal Bankda Whole-Time Director under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirement) Regulation, 20158 Aug 2026 · Company Update / Resignation of Director
Pursuant to Regulation 29(1)(a) of SEBI (LODR) Regulation 2015, we are pleased to inform that 2/2026-27 Meeting of the Board of Directors of the company is scheduled to be held on Tuesday ....6 Aug 2026 · Corp. Action / Dividend
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve we are pleased to ....6 Aug 2026 · Board Meeting / Board Meeting
Certificate for compliance of regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 30th June, 202610 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notice for Trading window Closure for the financials of the quarter ended 30.06.202625 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.202623 May 2026 · Company Update / Newspaper Publication
Pursuant to regulation 33(3)(d) of SEBI LODR Regulations, 2015 we are pleased to submit the financials for the year ended on 31st March, 202622 May 2026 · Result / Financial Results
Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015, we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors' Report thereon by ....22 May 2026 · Board Meeting / Outcome of Board Meeting
In terms of REG 24A of Listing Regulations, as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March, 202618 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
In terms of REG 24A of Listing Regulations, as amended read with master circular we hereby submit the Annual Secretarial Compliance Report for the year ended 31st March, 202618 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Pursuant to Regulation ....13 May 2026 · Board Meeting / Board Meeting
Pursuant to Reg 30 we want to inform that the company has purchased a property4 May 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.1000	23 Sep 2026	23 Sep 2026	—

Board meetings

11 Aug 2026 Board Meeting - Financial Results